Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. LifeMD, Inc.
  6. News
  7. Summary
    LFMD   US53216B1044

LIFEMD, INC.

(LFMD)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

LIFEMD, INC. : Change in Directors or Principal Officers (form 8-K)

07/02/2021 | 05:23pm EDT

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.



COO Compensation


Effective June 29, 2021, LifeMD, Inc. (the "Company") and Brad Roberts, its Chief Operating Officer, entered into the Second Amendment (the "Amendment") to the Amended and Restated Employment Agreement dated December 21, 2020 between the Company and Mr. Roberts (as first amended on June 15, 2021) to provide that Mr. Roberts is eligible to receive up to 300,000 restricted stock units of the Company's common stock, par value $0.01 (the "RSUs"), which will vest subject to the Company's Telemedicine Brands (as defined in the Amendment) achieving certain revenue milestones. The RSUs will also vest upon a Change of Control (as defined in the Amendment).

Item 5.02 of this Current Report on Form 8-K contains only a brief description of the material terms of the Amendment and does not purport to be a complete description of the rights and obligations of the parties to the Amendment, and such description is qualified in its entirety by reference to the full text of the Amendment, which will be filed with the Quarterly Report on Form 10-Q for the quarter ended June 30, 2021.

© Edgar Online, source Glimpses

All news about LIFEMD, INC.
09/22LIFEMD, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
09/21LIFEMD : to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference
AQ
09/20LIFEMD, INC.(NASDAQCM : LFMD) added to S&P Global BMI Index
CI
09/15INSIDER BUY : LifeMD
MT
09/13LIFEMD : Industry veteran brings deep financial and management expertise to LifeMD as comp..
PU
09/13LIFEMD, INC. : Change in Directors or Principal Officers, Other Events (form 8-K)
AQ
09/13LIFEMD : Appoints Seasoned Investor Naveen Bhatia to Board of Directors
AQ
09/13LifeMD, Inc. Appoints Naveen Bhatia to its Board of Directors
CI
09/08LIFEMD : to Present at the H.C. Wainwright Annual Global Investment Conference
AQ
08/30LIFEMD : to Adopt Prescryptive Health Digital Pharmacy, Prescriptions Platform for Telehea..
MT
More news
Analyst Recommendations on LIFEMD, INC.
More recommendations
Financials (USD)
Sales 2021 97,8 M - -
Net income 2021 -57,3 M - -
Net Debt 2021 - - -
P/E ratio 2021 -3,22x
Yield 2021 -
Capitalization 183 M 183 M -
Capi. / Sales 2021 1,87x
Capi. / Sales 2022 1,26x
Nbr of Employees 56
Free-Float 66,8%
Chart LIFEMD, INC.
Duration : Period :
LifeMD, Inc. Technical Analysis Chart | LFMD | US53216B1044 | MarketScreener
Technical analysis trends LIFEMD, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Last Close Price 6,89 $
Average target price 30,00 $
Spread / Average Target 335%
EPS Revisions
Managers and Directors
Justin Schreiber Chairman & Chief Executive Officer
Alexander Mironov President
Marc Benathen Chief Financial Officer
Joseph V. DiTrolio Independent Director & Chief Medical Officer-US
Stefan Galluppi Director & Chief Technology Officer
Sector and Competitors
1st jan.Capi. (M$)
LIFEMD, INC.5.51%183
AMAZON.COM, INC.4.88%1 734 822
JD.COM, INC.-15.84%114 829
WAYFAIR INC.21.60%28 530
ETSY, INC.25.26%28 208
ALLEGRO.EU SA-29.59%15 534